Burning Rock Biotech (BNR) Inventory (2019 - 2026)

Burning Rock Biotech's Inventory history runs 8 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• In Q1 2026, Inventory fell 12.7% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (down 12.7% YoY), while the FY2025 annual figure was $6.9 million, down 19.04% from the prior year.
• Inventory for Q1 2026 stood at $7.9 million, down from $8.0 million in the prior quarter.
• The five-year high for Inventory was $21.1 million in Q3 2022, with the low at $7.5 million in Q4 2024.
• The 5-year median for Inventory is $9.5 million (2024), against an average of $12.2 million.
• The sharpest annual moves came in 2022 and 2023: Inventory surged 37.63% in 2022, then tumbled 47.69% in 2023.
• Burning Rock Biotech's Inventory stood at $18.3 million in 2022, then tumbled by 47.69% to $9.6 million in 2023, then dropped by 21.92% to $7.5 million in 2024, then climbed by 7.33% to $8.0 million in 2025, then retreated by 2.02% to $7.9 million in 2026.
• Business Quant data shows BNR's Inventory at $7.9 million in Q1 2026, $8.0 million in Q4 2025, and $7.7 million in Q3 2025.